Intranasal COVID-19 vaccines: From bench to bed

Currently licensed COVID-19 vaccines are all designed for intramuscular (IM) immunization. However, vaccination today failed to prevent the virus infection through the upper respiratory tract, which is partially due to the absence of mucosal immunity activation. Despite the emerging severe acute res...

Descripción completa

Detalles Bibliográficos
Autores principales: Alu, Aqu, Chen, Li, Lei, Hong, Wei, Yuquan, Tian, Xiaohe, Wei, Xiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785603/
https://www.ncbi.nlm.nih.gov/pubmed/35085851
http://dx.doi.org/10.1016/j.ebiom.2022.103841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785603/
https://www.ncbi.nlm.nih.gov/pubmed/35085851
http://dx.doi.org/10.1016/j.ebiom.2022.103841

Ejemplares similares